Literature DB >> 765024

Immunosuppression with cyclophosphamide in the dog.

C W Putnam, C G Halgrimson, C G Groth, N Kashiwagi, K A Porter, T E Starzl.   

Abstract

Cyclophosphamide significantly diminished the canine humoral antibody response to sheep red blood cells and tended to prevent arterial lesions in renal homografts. However, cyclophosphamide failed to prolong renal homograft survival when administered to dogs as the sole immunosuppressive agent, and it did not add to the effectiveness of azathioprine when given as a supplement to the azathioprine and administered simultaneously or sequentially.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 765024      PMCID: PMC1538282     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO].

Authors:  N BROCK; H J HOHORST
Journal:  Arzneimittelforschung       Date:  1963-12

2.  SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE.

Authors:  M FOX
Journal:  Transplantation       Date:  1964-07       Impact factor: 4.939

3.  EFFECT OF CYCLOPHOSPHAMIDE IN THE ADRENALECTOMIZED ANIMAL.

Authors:  J B TIPTON
Journal:  Surg Forum       Date:  1964

4.  DIURETIC ACTION OF CYCLOPHOSPHAMIDE IN EXPERIMENTAL ANIMALS.

Authors:  M S ZEDECK; L B MELLETT
Journal:  Med Bull (Ann Arbor)       Date:  1964 May-Jun

5.  PROLONGATION OF CANINE RENAL HOMOGRAFT SURVIVAL BY ANTIMETABOLITES.

Authors:  C F ZUKOSKI; J M CALLAWAY; W G RHEA
Journal:  Transplantation       Date:  1963-07       Impact factor: 4.939

6.  EXPERIMENTAL LUNG TRANSPLANTATION.

Authors:  I W MACPHEE; E S WRIGHT
Journal:  Lancet       Date:  1964-01-25       Impact factor: 79.321

7.  DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.

Authors:  M C BERENBAUM; I N BROWN
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

8.  INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN.

Authors:  A W FRISCH; G H DAVIES
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

9.  Effect of cyclophosphoramide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB) contact dermatitis) in the guinea-pig.

Authors:  H C MAGUIRE; H I MAIBACH
Journal:  J Invest Dermatol       Date:  1961-11       Impact factor: 8.551

10.  Survival of homografts of the intestine with and without immunosuppression.

Authors:  F W Preston; F Macalalad; T J Wachowski; D A Randolph; J V Apostol
Journal:  Surgery       Date:  1966-12       Impact factor: 3.982

View more
  4 in total

1.  Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.

Authors:  A Langer; L A Valdivia; N Murase; J Woo; S Celli; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

2.  Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

Authors:  N Murase; T E Starzl; A J Demetris; L Valdivia; M Tanabe; D Cramer; L Makowka
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

3.  The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.

Authors:  C G Winearls; J W Fabre; P R Millard; P J Morris
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 4.  Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Authors:  Rita Diehl; Fabienne Ferrara; Claudia Müller; Antje Y Dreyer; Damian D McLeod; Stephan Fricke; Johannes Boltze
Journal:  Cell Mol Immunol       Date:  2016-10-10       Impact factor: 11.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.